This October, SpiroChem will participate in six international conferences spanning medicinal chemistry, process R&D, biologics, ADCs and peptide drug discovery.
The team will be present at the following meetings:
16th Swiss Course on Medicinal Chemistry 2026
October 4–9, 2026 | Leysin, Switzerland
Organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society, the five-day course focuses on modern aspects of small molecule drug discovery, including hit generation, lead finding and lead optimization.
SpiroChem is a sponsor of the course and Gerhard Mueller, PhD – CSO is a co-organizer.
CPHI Milan 2026
October 6–8, 2026 | Milan, Italy
CPHI brings together companies and industry professionals from across the global pharmaceutical supply chain, covering areas including APIs, bioproduction, contract services, CROs, fine chemicals, finished dosage, integrated pharma, packaging and drug delivery.
Attending for SpiroChem:
Florent Beaufils, PhD – COO
Alec Morrison, PhD – Director of Early PR&D and Innovation
World ADC San Diego 2026
October 13–14, 2026 | San Diego, United States
World ADC San Diego brings together the global ADC community to exchange on developments spanning discovery chemistry, preclinical research, clinical development, process development and manufacturing.
Attending for SpiroChem:
Laurence Jung, PhD – Innovative Solution Developer
Festival of Biologics Basel 2026
October 13–15, 2026 | Basel, Switzerland
Festival of Biologics covers the biologics value chain from discovery through development, manufacturing and market access, bringing together participants from across pharma, biotech, academia and the wider biologics ecosystem.
Attending for SpiroChem:
Florent Beaufils, PhD – COO
European Peptide Drug Summit 2026
October 14–15, 2026 | Munich, Germany
The summit brings together industry leaders and peptide innovators to discuss developments across peptide discovery, synthesis, delivery, manufacturing and therapeutic applications.
Gerhard Mueller, PhD – CSO will give a presentation titled:
“FROM PEPTIDES TO DRUGS: EXPANDING THE FRONTIERS OF MEDICINAL CHEMISTRY”
His talk will address the progression of peptide hits toward more tractable and drug-like candidate designs, the use of peptidomimetic tools to reduce liabilities and improve target engagement, and the refinement of macrocycles through tailored residues, linkers and conformational control.
21st Annual Peptide Therapeutics Symposium
October 20–21, 2026 | La Jolla, California
The Peptide Therapeutics Symposium brings together experts from academia and the biopharmaceutical industry to exchange on advances in peptide-based drug discovery and therapeutic candidate development.
Attending for SpiroChem:
Gerhard Mueller, PhD – CSO
Laurence Jung, PhD – Innovative Solution Developer
Across these meetings, SpiroChem will engage with scientific and industry communities working across drug discovery and development, from medicinal and process chemistry to ADCs, biologics and peptide therapeutics.
